Amylyx Pharmaceuticals, Inc.

Direct answer

Amylyx Pharmaceuticals, Inc. is publicly traded on NASDAQ under the ticker AMLX.

Amylyx Pharmaceuticals, Inc. operates as a clinical-stage biopharmaceutical firm, primarily focused on creating therapies for amyotrophic lateral sclerosis (ALS) and various other neurodegenerative conditions. A key asset in its developmental pipeline is AMX0035, a proprietary dual UPR-Bax apoptosis inhibitor. This compound, which integrates sodium phenylbutyrate and taurursodiol, is under investigation for treating...

Can you invest in Amylyx Pharmaceuticals, Inc.?

Yes. Amylyx Pharmaceuticals, Inc. trades publicly on NASDAQ as AMLX.

View deeper analysis

View detailed research on MarketSnap, including financials, valuation tools, and analyst context.

Open research for Amylyx Pharmaceuticals, Inc.

Detailed equity research is provided by MarketSnap.